(Reuters) – AbbVie Inc (NYSE:) is nearing a deal to buy Botox-maker Allergan (NYSE:) PLC for more than $60 billion (47 billion pounds), the Wall Street Journal reported on Tuesday, citing people familiar with the matter.
Both companies did not immediately respond to Reuters’ request for comment.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.